Anthem Biosciences Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
ANTHEM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Anthem Biosciences Limited has submitted a routine compliance certificate to the stock exchanges under SEBI Regulation 74(5) for the quarter ended December 31, 2025. The certificate was issued by Kfin Technologies Limited, the company's Registrar and Transfer Agent, confirming that details of securities dematerialized and rematerialized during the quarter have been furnished to both NSDL and CDSL (the two central depositories in India) and to the stock exchanges where the company's shares are listed. The filing was made by Divya Prasad, Company Secretary & Compliance Officer, on January 7, 2026. There are no financial figures, transactions, or business updates disclosed in this filing.
This is a standard, routine regulatory compliance filing with no material impact on the company's operations, financials, or share price. Shareholders do not need to take any action.